Portfolio overhauls illustrate Vietnam’s potential

Portfolio overhauls illustrate Vietnam’s potential

Vietnam’s healthcare and pharmaceutical market has become heated as investors step up the restructuring of their investment portfolios.
Pharmaceutical supply chains under threat of tariff changes

Pharmaceutical supply chains under threat of tariff changes

Pharma companies have outlined concerns over how potential tariffs could impact the supply chains. Gregoris Charitonos, chairman of the European Standards Medicines Sector Committee under the European Chamber of Commerce in Vietnam, talked to VIR’s Bich Thuy about the issues in particular.
Pharma players tackle tariff impacts

Pharma players tackle tariff impacts

Pharma companies involved in Vietnam are making more strategic moves to ease potential impacts in the face of US tariff threats.
Is pharmaceutical market benefiting from EVFTA?

Is pharmaceutical market benefiting from EVFTA?

Known as one of Vietnam’s most notable new-generation trade deals, the EU-Vietnam Free Trade Agreement (EVFTA) marks a significant milestone in the 30-year journey of cooperation and development between both sides. Over five years of implementation, it has left a profound impact on Vietnam’s economy and its pharmaceutical market in particular.
Stimulating year ahead for pharma

Stimulating year ahead for pharma

Vietnam’s pharmaceutical market is expected to have a year of optimism after experiencing a multicoloured gamut in 2024.
Pharma seeks tech transfer incentives

Pharma seeks tech transfer incentives

With growing interest in technology transfer for pharmaceutical and vaccine manufacturing in Vietnam, multinational corporations are urging the government to issue more supporting policies.
Pharma to experience robust growth

Pharma to experience robust growth

Vietnam healthcare market size is estimated to reach $23.7 billion and grow at an average rate of 7.5 per cent annually from 2023 to 2028. Healthcare expenditure per capita is also projected to increase from $237 to $328 in that time.
Vietnam's pharmaceutical market boasts immense potential

Vietnam's pharmaceutical market boasts immense potential

Vietnam has among the highest pharmaceutical industry growth rates worldwide.
Pharmaceutical players seek expansion of rights in Vietnam

Pharmaceutical players seek expansion of rights in Vietnam

While continuing to make positive business results in Vietnam’s pharma market in the first half of 2024, multinationals are seeking an expansion of their rights.
Legal reform can be key to pharma innovation bonanza

Legal reform can be key to pharma innovation bonanza

As countries are in the race to latch onto new investment from the innovative pharma industry, Vietnam is being urged to improve its legal system to increase its competitiveness.
Pharma groups step up competition

Pharma groups step up competition

More international pharma and medical device businesses are rushing to venture further in Vietnam, anticipating wide growth potential.
The legal adaption measures expected from pharma groups

The legal adaption measures expected from pharma groups

Multinational corporations in Vietnam are expecting changes in drug rules to make more business and investment progress. Tran Ngoc Anh, representative of the US-ASEAN Business Council, discussed with VIR’s Bich Thuy the current barriers and expectations stemming from legal adjustments.
Foreign firms continue to see Vietnam as good investment location

Foreign firms continue to see Vietnam as good investment location

While a number of foreign companies have moved part of their production or orders to other countries, many still see Vietnam as a good location for investment in the long term.
Mitigating procedural delays in pharmaceutical market

Mitigating procedural delays in pharmaceutical market

While Vietnam has witnessed positive developments in the pharmaceutical and healthcare spheres over the past few years, some issues still need to be ironed out.
Imexpharm continues to push limits of possibility

Imexpharm continues to push limits of possibility

As Vietnam has become an emerging pharmaceutical market, Imexpharm is eager to invest in innovation and technology to capitalise on rising healthcare demand.
1 2